在淋巴恶性肿瘤治疗中，奥加伊妥珠单抗（ino）虽对 b 细胞急性淋巴细胞白血病（b-all）疗效高，但 cd22 表达及白血病对 ino 敏感性的影响因素不明。研究人员通过多组学分析等，发现 ebf1 是 cd22 表达关键调节因子，影响 ino 疗效，为精准治疗提供依据。

Inhaled nitric oxide (iNO) has quickly become a standard therapy for term and near-term infants with hypoxic respiratory failure and persistent pulmonary hypertension. Its effect on the lung is ...

Use of inhaled nitric oxide (iNO) among pediatric patients has increased since 2005 and, during a 10-year time period, mortality rates dropped modestly as the therapeutic approach was applied to a ...

Use of inhaled nitric oxide (iNO) among pediatric patients has increased since 2005 and, during a 10-year time period, mortality rates dropped modestly as the therapeutic approach was applied to a ...

Use of inhaled nitric oxide (iNO) among pediatric patients has increased since 2005 and, during a 10-year time period, mortality rates dropped modestly as the therapeutic approach was applied to a ...

PLYMOUTH MEETING, Pa., Nov. 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect ...

Many premature infants throughout the United States continue to receive inhaled nitric oxide (iNO) during their NICU stay, despite the lack of evidence to support its use. Whether or not a preemie ...

Ino Technologies has produced a handheld device that combines weather data with lightning detection, as an all-in-one way to be prepared for rough weather. Skip to main content.